Zhangzhou Pientzehuang Pharmaceutical., Ltd

SHSE:600436 Stock Report

Market Cap: CN¥142.4b

Zhangzhou Pientzehuang Pharmaceutical Balance Sheet Health

Financial Health criteria checks 6/6

Zhangzhou Pientzehuang Pharmaceutical has a total shareholder equity of CN¥14.6B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 7.3%. Its total assets and total liabilities are CN¥18.0B and CN¥3.4B respectively. Zhangzhou Pientzehuang Pharmaceutical's EBIT is CN¥3.5B making its interest coverage ratio -27.1. It has cash and short-term investments of CN¥3.3B.

Key information

7.3%

Debt to equity ratio

CN¥1.06b

Debt

Interest coverage ratio-27.1x
CashCN¥3.27b
EquityCN¥14.60b
Total liabilitiesCN¥3.39b
Total assetsCN¥17.99b

Recent financial health updates

Recent updates

Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Share Price Could Signal Some Risk

Nov 25
Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Share Price Could Signal Some Risk

These 4 Measures Indicate That Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Is Using Debt Safely

Nov 07
These 4 Measures Indicate That Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Is Using Debt Safely

Earnings Beat: Zhangzhou Pientzehuang Pharmaceutical., Ltd Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Oct 22
Earnings Beat: Zhangzhou Pientzehuang Pharmaceutical., Ltd Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Estimating The Intrinsic Value Of Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHSE:600436)

Sep 08
Estimating The Intrinsic Value Of Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHSE:600436)

Earnings Miss: Zhangzhou Pientzehuang Pharmaceutical., Ltd Missed EPS By 39% And Analysts Are Revising Their Forecasts

Aug 20
Earnings Miss: Zhangzhou Pientzehuang Pharmaceutical., Ltd Missed EPS By 39% And Analysts Are Revising Their Forecasts

Subdued Growth No Barrier To Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Price

Jul 12
Subdued Growth No Barrier To Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Price

These 4 Measures Indicate That Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Is Using Debt Safely

May 27
These 4 Measures Indicate That Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Is Using Debt Safely

Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Business Is Yet to Catch Up With Its Share Price

Feb 28
Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Business Is Yet to Catch Up With Its Share Price

Financial Position Analysis

Short Term Liabilities: 600436's short term assets (CN¥15.8B) exceed its short term liabilities (CN¥3.1B).

Long Term Liabilities: 600436's short term assets (CN¥15.8B) exceed its long term liabilities (CN¥289.5M).


Debt to Equity History and Analysis

Debt Level: 600436 has more cash than its total debt.

Reducing Debt: 600436's debt to equity ratio has reduced from 12% to 7.3% over the past 5 years.

Debt Coverage: 600436's debt is well covered by operating cash flow (106%).

Interest Coverage: 600436 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies